Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines

Keyphrases

• Basal Cell Carcinoma 100%
• High Risk 18%
• Difficult-to-treat 18%
• Superficial Basal Cell Carcinoma 18%
• Nevoid Basal Cell Carcinoma Syndrome 18%
• High-risk Areas 18%
• Clinical Trials 9%
• Radiotherapy 9%
• Therapeutic Potential 9%
• Cell Death 9%
• Low Risk 9%
• Effective Treatment 9%
• Cancer Treatment 9%
• Anatomical Location 9%
• Vismodegib 9%
• Malignant Tumor 9%
• Hedgehog Inhibitor 9%
• New Classification 9%
• Carcinoma Cells 9%
• European Organizations 9%
• Multidisciplinary Tumor Board 9%
• Elderly Patients 9%
• Locally Advanced 9%
• Sonidegib 9%
• European Associations 9%
• Curettage 9%
• Dermato-oncology 9%
• Anti-PD-1 Antibody 9%
• Topical Therapy 9%
• Fluorouracil 9%
• White Population 9%
• Cryotherapy 9%
• Photodynamic Therapy 9%
• Electrocautery 9%
• Multiple Basal Cell Carcinomas 9%
• Imiquimod 5% 9%
• Advanced BCC 9%
• Nodular Basal Cell Carcinoma 9%
• Metastatic BCC 9%
• Complete Surgery 9%
• Skin Examination 9%
• Ambiguous Lesion 9%
• Controlled Surgery 9%
• Laser Ablation 9%

Medicine and Dentistry

• Photochemotherapy 9%